Patents by Inventor Qingjun Zhou
Qingjun Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260273625Abstract: A method of laser-electron beam composite additive manufacturing, may include: melting metal powder by using an electron beam as heat source to form molten pool on substrate surface; acquiring average temperature, surface fluctuations, and defect occurrence rate of the molten pool in real time; when simultaneously the average temperature reaches set stable temperature range, the surface fluctuations decrease to set standard range, and the defect occurrence rate is lower than a set threshold, switching to using a laser as main heat source and the electron beam as auxiliary heat source; and, continuing to melt metal powder until a deposition is formed; during collaborative operation process of laser and electron beam, constructing energy distribution map based on multiple detection data to obtain temperature and morphology distributions of molten pool; and, adjusting power parameters of laser and electron beam in real time based on variations in temperature and morphology of molten pool.Type: ApplicationFiled: March 10, 2026Publication date: September 17, 2026Inventors: Jilai WANG, Baojian LIU, Qingjun ZHOU, Ning GUO, Quhao LI, Yi WAN
-
Publication number: 20260258536Abstract: The present invention discloses a hot-rolled strip steel and manufacturing method therefor. The hot-rolled strip steel comprises the following components in mass percentage: C: 0.04-0.09%, Si?0.50%, Mn: 0.10-1.50%, P?0.03%, S?0.01%, Al?0.60%, Cr: 1.5-4.5%, Cu: 0.10-0.60%, Ti: 0.05-0.18%, Ni?0.30%, Nb?0.06%, N?0.008%, and the balance being Fe and inevitable impurities, and the hot-rolled strip steel further satisfies: 2Mn+Cr?6%, with element symbols being substituted with mass percentages of corresponding chemical elements in the hot-rolled strip steel for calculation. The present invention shows excellent resistance to atmospheric corrosion and mechanical properties.Type: ApplicationFiled: June 15, 2023Publication date: September 3, 2026Inventors: Mingzhuo Bai, Zigang Li, Ana Yang, Fengbin Li, Donghui Wen, Qingjun Zhou, Fengming Song, Xiaoping Hu, Haiting Liu, Sheng Liu, Hua Zhang
-
Publication number: 20260256718Abstract: Use of an agent targeting a norepinephrine-adrenergic receptor beta 2 (NE-Adrb2) signaling pathway in preparation of a drug for treating dry eye disease (DED) is provided, belonging to the technical field of DED therapeutics. Use of an agent targeting an NE-Adrb2 signaling pathway in preparation of a drug for treating DED. Specifically, the agent targeting the NE-Adrb2 signaling pathway includes an agent that blocks the NE-Adrb2 signaling pathway. It is found that the NE-Adrb2 signaling pathway directly contributes to the pathogenesis of DED, and targeting the NE-Adrb2 signaling pathway enables the development of therapeutic agents for DED. In particular, an adrenergic receptor beta 2 (Adrb2) blocker can alleviate the severity of DED, thereby achieving therapeutic efficacy. This discovery provides a novel therapeutic strategy for the prevention and treatment of DED.Type: ApplicationFiled: September 4, 2025Publication date: September 3, 2026Applicant: EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITYInventors: Qingjun ZHOU, Mingli QU, Lixin XIE, Xiaofei BAI
-
Publication number: 20260158018Abstract: The present disclosure belongs to the technical field of drug preparation and relates to a perfusate containing nicotinamide (NAM) for intraocular surgery, a method of preparation and use thereof. Provided is use of NAM in perfusates for intraocular surgery. In the present disclosure, the perfusate for intraocular surgery improved with NAM may inhibit corneal endothelial cell damage caused by phacoemulsification, reduce corneal edema caused by phacoemulsification, avoid a significant decrease in the number of corneal endothelial cells (CECs) caused by phacoemulsification, promote recovery of corneal transparency after phacoemulsification, promote recovery of the normal corneal thickness, maintain the normal density and cellular morphology of CECs, and regular expression of functional proteins, and reduce complications caused by phacoemulsification. The present disclosure may provide an effective strategy for realizing the rapid recovery of normal visual function of cataract patients after surgery.Type: ApplicationFiled: November 15, 2023Publication date: June 11, 2026Applicant: EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG EYE INSTITUTE, QINGDAO EYE HOSPITAL OFInventors: Lixin XIE, Xiaomin LIU, Zongyi LI, Xiaoming WU, Qingjun ZHOU, Ping LIN, Haoyun DUAN
-
Publication number: 20260115358Abstract: The present invention discloses a low-swelling decellularized cornea, its preparation method, and applications. The decellularized cornea is obtained by incorporating methacrylated compounds into a decellularized corneal matrix. The decellularized cornea exhibits thermosensitive and photopolymerizable properties, capable of exuding monomer polymers at temperatures above 25° C. and forming a stable biological adhesion layer on the recipient bed through photopolymerization. The decellularized cornea features abundant material sources and enables rapid trauma repair without surgical sutures.Type: ApplicationFiled: August 12, 2024Publication date: April 30, 2026Inventors: Weiyun SHI, Long ZHAO, Ting WANG, Qingjun ZHOU, Zhen SHI
-
Publication number: 20250361589Abstract: The present invention provides a hot-rolled strip steel and manufacturing method therefor. The hot-rolled strip steel comprises the following components in mass percentage: C: 0.04 to 0.15%, Si?0.50%, Mn: 0.30 to 2.00%, Cr: 1.5 to 4.5%, Cu: 0.10 to 0.60%, P?0.03%, S?0.01%, and Al: 0.01 to 0.60%, with the balance being Fe and unavoidable impurities; and further satisfies: 2.5%?2Mn+Cr?6.0%, with elemental symbols being substituted with mass percentages of corresponding elements in the hot-rolled strip steel for calculation. The hot-rolled strip steel of the present invention exhibits excellent resistance to atmospheric corrosion and mechanical properties, and can be directly used for supporting bracket structural parts such as guardrails, mast towers and photovoltaics without coating on the surface.Type: ApplicationFiled: June 15, 2023Publication date: November 27, 2025Inventors: Mingzhuo Bai, Zigang Li, Ana Yang, Fengbin Li, Donghui Wen, Qingjun Zhou, Fengming Song, Xiaoping Hu, Haiting Liu, Sheng Liu, Hua Zhang
-
Publication number: 20250305151Abstract: Disclosed is a stabilization treatment liquid for a 690 MPa-grade weather-resistant bridge steel member. The content in percentage by mass of each component of the stabilization treatment liquid is as follows: the content of ferric trichloride is 3-7%; the content of sodium bisulfite is 1-2%; the content of chromium sulfate is 3-6%; the content of potassium permanganate is 1-4%; the content of polypropylene glycol is 1-2%; the content of sodium carboxymethyl cellulose is 2-5%; and the remainder is deionized water. Also provided is a method for performing stabilization treatment by using the stabilization treatment liquid. According to the present invention, stabilization treatment for a rust layer of a 690 MPa-grade weather-resistant bridge steel member can be achieved, and after treatment, a brown rust layer having uniform color and no rust liquid flow is formed on the surface of the 690 MPa-grade weather-resistant bridge steel member.Type: ApplicationFiled: May 10, 2023Publication date: October 2, 2025Applicant: BAOSHAN IRON & STEEL CO., LTD.Inventors: Fengjun LANG, Jiangwen LI, Zhongbo DONG, Peng CHENG, Yong CHEN, Tao PANG, Ying MA, Qingjun ZHOU
-
Publication number: 20250296965Abstract: Use of a recombinant transforming growth factor beta induced (TGFBI) protein in lattice corneal dystrophy (LCD) is provided, belonging to the technical field of biomedicine. Use of a recombinant TGFBI protein and a recombinant TGFBI protein-expressing reagent in preparation of a medicament for treating LCD are provided. It is confirmed that dropping eye drops of the recombinant TGFBI protein can promote the repair of corneal epithelial damages in an LCD mouse model; corneal intrastromal injection of the recombinant TGFBI protein can promote the repair of corneal epithelial damages in the LCD mouse model; and limbal intrastromal injection of an adeno-associated virus (AAV) vector carrying a Tgfbi gene can promote the repair of epithelial damages in a TGFBI point mutation-carrying mouse. Therefore, the recombinant TGFBI protein-related reagents exhibit a potential to treat the LCD.Type: ApplicationFiled: June 6, 2024Publication date: September 25, 2025Applicant: EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITYInventors: Lixin XIE, Qingjun ZHOU, Bining ZHANG, Lin CONG
-
Patent number: 12400054Abstract: The present disclosure provides a method for building a finite element model of corneal endothelial cells, including: importing a standard corneal model into finite element pre-processing software, and generating 2D meshes, to obtain a basic mesh model; importing a detailed geometric model of corneal endothelial cells; determining a complete corneal endothelial cell model according to the basic mesh model and the detailed geometric model; and performing calculation according to the complete corneal endothelial cell model. The present disclosure can improve the efficiency and effect of building a finite element model of corneal endothelial cells.Type: GrantFiled: November 5, 2024Date of Patent: August 26, 2025Assignee: Shandong First Medical University Affiliated Eye Institute (SHANDONG EYE INSTITUTE/QINGDAO EYE HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY)Inventors: Lixin Xie, Dongfang Li, Zongyi Li, Qingjun Zhou, Ping Lin, Xinhang Wang, Chaoying Wang
-
Patent number: 12324769Abstract: A preparation method of a double-network versatile hydrogel with antibacterial and drug sequential release capabilities is provided in the present disclosure, belonging to the technical field of biological corneas. The preparation method includes the following steps: mixing filipin protein-methacrylate, glycidyl methacrylate functionalized quaternized chitosan, polydeoxyribonucleotide, and lithium phenyl(2,4,6-trimethylbenzoyl) phosphinate with drug-loaded micelles, followed by cross-linking under irradiation of ultraviolet to construct a double-network versatile hydrogel with antibacterial and drug sequential release capabilities.Type: GrantFiled: October 11, 2024Date of Patent: June 10, 2025Assignee: EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITYInventors: Hengrui Zhang, Qingjun Zhou, Shuqin Meng, Huifang Ren
-
Patent number: 12319947Abstract: A method for preparing (S)-nicotine by reduction includes conducting a reduction process on an alkene compound as shown in Formula I and/or an iminium cation compound as shown in Formula II, thereby producing (S)-nicotine. The method is simple, safe, reliable, and yields both high purity and high quantities of (S)-nicotine production.Type: GrantFiled: November 28, 2023Date of Patent: June 3, 2025Assignee: PORTON PHARMA SOLUTIONS LTD.Inventors: Wenqing Lin, Hongjie Zheng, Xiaobo Liu, Zecong Chen, Lingyu Li, Qingjun Zhou, Songhe Wang, Yongtang Yue, Jicheng Hu, Yue Zhang, Shanshan Miao
-
Publication number: 20250170305Abstract: A transparent sclera-based corneal repair material, and a preparation method and use thereof, belonging to the technical field of medical repair materials are disclosed. The sclera, a natural biological material that is convenient to obtain, is used as a source of the corneal repair material. The opaque sclera is hyalinized by compressing. Carboxyl groups on a scleral fibrin are activated by cross-linking, such that amino groups of the sclera combine with the carboxyl groups to form an amide bond. The amide bond belongs to a covalent bond and has a desirable stability, thereby maintaining a transparency of the sclera after the compressing. Therefore, the transparent sclera can be used as a transparent corneal tissue repair material.Type: ApplicationFiled: January 9, 2023Publication date: May 29, 2025Inventors: Weiyun SHI, Qingjun ZHOU, Long ZHAO, Xiuli SUN, Zhen SHI
-
Publication number: 20250169985Abstract: A preparation method of a double-network versatile hydrogel with antibacterial and drug sequential release capabilities is provided in the present disclosure, belonging to the technical field of biological corneas. The preparation method includes the following steps: mixing filipin protein-methacrylate, glycidyl methacrylate functionalized quaternized chitosan, polydeoxyribonucleotide, and lithium phenyl(2,4,6-trimethylbenzoyl) phosphinate with drug-loaded micelles, followed by cross-linking under irradiation of ultraviolet to construct a double-network versatile hydrogel with antibacterial and drug sequential release capabilities.Type: ApplicationFiled: October 11, 2024Publication date: May 29, 2025Applicant: Eye Institute of Shandong First Medical UniversityInventors: Hengrui ZHANG, Qingjun ZHOU, Shuqin MENG, Huifang REN
-
Publication number: 20250165669Abstract: The present disclosure provides a method for building a finite element model of corneal endothelial cells, including: importing a standard corneal model into finite element pre-processing software, and generating 2D meshes, to obtain a basic mesh model; importing a detailed geometric model of corneal endothelial cells; determining a complete corneal endothelial cell model according to the basic mesh model and the detailed geometric model; and performing calculation according to the complete corneal endothelial cell model. The present disclosure can improve the efficiency and effect of building a finite element model of corneal endothelial cells.Type: ApplicationFiled: November 5, 2023Publication date: May 22, 2025Applicant: Shandong First Medical University Affiliated Eye Institute (SHANDONG EYE INSTITUTE/QINGDAO EYE HOSInventors: Lixin Xie, Dongfang Li, Zongyi Li, Qingjun Zhou, Ping Lin, Xinhang Wang, Chaoying Wang
-
Patent number: 12106970Abstract: The present disclosure discloses a pattern sheet, a semiconductor intermediate product, and a hole etching method. The pattern sheet includes a substrate, a dielectric layer, and a mask structure. The mask structure includes a multi-layer mask layer. An uppermost mask layer is a photoresist layer. A thickness of each layer of the mask layer and etching selectivity ratios between the layers below the mask layer satisfy that in each two neighboring layers of the mask layer, a lower layer of the mask layer is etched to form a through-hole penetrating a thickness of the lower layer of the mask layer, a remaining thickness of the upper layer of the mask layer is greater than or equal to zero.Type: GrantFiled: April 2, 2021Date of Patent: October 1, 2024Assignee: BEIJING NAURA MICROELECTRONICS EQUIPMENT CO., LTD.Inventors: Qiushi Xie, Xiaoping Shi, Qingjun Zhou, Dongsan Li, Chun Wang, Yiming Zhang
-
Patent number: 12090156Abstract: In view of the problem that the current prevention and treatment manners for corneal neovascularization (CNV) may cause complications, the present disclosure provides an application of CB-839 in preparation of a drug for inhibiting CNV. The CB-839-loaded drug of the present disclosure can significantly inhibit CNV in mice and reduce the infiltration of inflammatory cells without obvious side effects, which makes up for the shortcoming of the prior art.Type: GrantFiled: February 15, 2023Date of Patent: September 17, 2024Assignee: INSTITUTE OF OPHTHALMOLOGY AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG INSTITUTE OF OPHTHALMOInventors: Weiyun Shi, Qingjun Zhou, Hongwei Wang, Bining Zhang
-
Patent number: 12076443Abstract: A preparation method of a nanozyme composite-based hybrid hydrogel eye drop includes synthesizing a tannin-coordinated silver/cobalt composite nanoparticle through a coordination reaction of cobalt chloride hexahydrate with ammonia water and an oxidation-reduction reaction of silver nitrate with tannin; and mixing the silver/cobalt composite nanoparticle with an acrylate-modified gelatin, conducting an ultrasonic treatment to allow complete dissolution, and irradiating a resulting mixture under ultraviolet (UV) light to obtain the nanozyme composite-based hybrid hydrogel eye drop. The preparation method of the present disclosure has simple operations and a short preparation time. The eye drop prepared by the preparation method shows a broad-spectrum bactericidal effect against a variety of bacteria and fungi, and has prominent preventive and therapeutic effects for bacterial and drug-resistant bacterial corneal infections.Type: GrantFiled: February 15, 2023Date of Patent: September 3, 2024Assignee: INSTITUTE OF OPHTHALMOLOGY AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG INSTITUTE OF OPHTHALMOLOGY, QINGDAO EYE HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY)Inventors: Qingjun Zhou, Weiyun Shi, Hongwei Wang, Fangying Song
-
Publication number: 20240261281Abstract: In view of the problem that the current prevention and treatment manners for corneal neovascularization (CNV) may cause complications, the present disclosure provides an application of CB-839 in preparation of a drug for inhibiting CNV. The CB-839-loaded drug of the present disclosure can significantly inhibit CNV in mice and reduce the infiltration of inflammatory cells without obvious side effects, which makes up for the shortcoming of the prior art.Type: ApplicationFiled: February 15, 2023Publication date: August 8, 2024Applicant: Institute of Ophthalmology Affiliated to Shandong First Medical University (Shandong Institute ofInventors: Weiyun SHI, Qingjun ZHOU, Hongwei WANG, Bining ZHANG
-
Publication number: 20240261231Abstract: A preparation method of a nanozyme composite-based hybrid hydrogel eye drop includes synthesizing a tannin-coordinated silver/cobalt composite nanoparticle through a coordination reaction of cobalt chloride hexahydrate with ammonia water and an oxidation-reduction reaction of silver nitrate with tannin; and mixing the silver/cobalt composite nanoparticle with an acrylate-modified gelatin, conducting an ultrasonic treatment to allow complete dissolution, and irradiating a resulting mixture under ultraviolet (UV) light to obtain the nanozyme composite-based hybrid hydrogel eye drop. The preparation method of the present disclosure has simple operations and a short preparation time. The eye drop prepared by the preparation method shows a broad-spectrum bactericidal effect against a variety of bacteria and fungi, and has prominent preventive and therapeutic effects for bacterial and drug-resistant bacterial corneal infections.Type: ApplicationFiled: February 15, 2023Publication date: August 8, 2024Applicant: Institute of Ophthalmology Affiliated to Shandong First Medical University (Shandong Institute ofInventors: Qingjun ZHOU, Weiyun SHI, Hongwei WANG, Fangying SONG
-
Publication number: 20240266182Abstract: The present disclosure discloses a pattern sheet, a semiconductor intermediate product, and a hole etching method. The pattern sheet includes a substrate, a dielectric layer, and a mask structure. The mask structure includes a multi-layer mask layer. An uppermost mask layer is a photoresist layer. A thickness of each layer of the mask layer and etching selectivity ratios between the layers below the mask layer satisfy that in each two neighboring layers of the mask layer, a lower layer of the mask layer is etched to form a through-hole penetrating a thickness of the lower layer of the mask layer, a remaining thickness of the upper layer of the mask layer is greater than or equal to zero.Type: ApplicationFiled: April 2, 2021Publication date: August 8, 2024Inventors: Qiushi XIE, Xiaoping SHI, Qingjun ZHOU, Dongsan LI, Chun WANG, Yiming ZHANG